Polyrizon Stock (NASDAQ:PLRZ)

Financials Chart

Previous Close

$1.39

52W Range

$0.55 - $1.20K

50D Avg

$1.01

200D Avg

$179.03

Market Cap

$9.06M

Avg Vol (3M)

$8.02M

Beta

-5.93

Div Yield

-

PLRZ Company Profile

Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel. The company's nasal sprays provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

IL

Employees

2

IPO Date

Oct 29, 2024

Website

PLRZ Performance

PLRZ Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	$-1.30M	$-635.00K	$-895.00K
Net Income	$-1.54M	$-600.00K	$-779.00K
EBITDA	$-1.18M	$-594.00K	$-772.00K
Basic EPS	-	$-0.16	$-0.20
Diluted EPS	-	$-0.16	$-0.20

Fiscal year ends in Dec 24 | Currency in USD